Embecta Corp. (EMBC)

NASDAQ: EMBC · IEX Real-Time Price · USD
13.13
+0.29 (2.26%)
May 24, 2024, 4:00 PM EDT - Market closed
2.26%
Market Cap 757.21M
Revenue (ttm) 1.13B
Net Income (ttm) 70.20M
Shares Out 57.67M
EPS (ttm) 1.21
PE Ratio 10.85
Forward PE 6.34
Dividend $0.60 (4.57%)
Ex-Dividend Date May 28, 2024
Volume 298,609
Open 12.78
Previous Close 12.84
Day's Range 13.13 - 13.13
52-Week Range 9.93 - 28.36
Beta 0.82
Analysts Sell
Price Target 13.00 (-0.99%)
Earnings Date May 9, 2024

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey. [Read more]

Sector Healthcare
Founded 1924
Employees 2,200
Stock Exchange NASDAQ
Ticker Symbol EMBC
Full Company Profile

Financial Performance

In 2023, Embecta's revenue was $1.12 billion, a decrease of -0.77% compared to the previous year's $1.13 billion. Earnings were $70.40 million, a decrease of -68.52%.

Financial Statements

Analyst Forecast

According to one analyst, the rating for EMBC stock is "Sell" and the 12-month stock price forecast is $13.0.

Price Target
$13.0
(-0.99% downside)
Analyst Consensus: Sell
Stock Forecasts

News

Embecta (EMBC) CEO on Diabetes Treatment Market

Embecta (EMBC) CEO Dev Kurdikar joins Oliver Renick to give an overview of the company and discuss its 2Q earnings. He also talks about the impact of GLP-1 drugs.

10 days ago - Schwab Network

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six mon...

18 days ago - GlobeNewsWire

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding sh...

19 days ago - GlobeNewsWire

embecta to Participate in Investor Events

PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management ...

26 days ago - GlobeNewsWire

embecta to Report Fiscal Second Quarter 2024 Financial Results

PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to...

4 weeks ago - GlobeNewsWire

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorshi...

2 months ago - GlobeNewsWire

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month peri...

3 months ago - GlobeNewsWire

embecta to Participate in the 11th Annual BTIG MedTech Conference

PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at the ...

3 months ago - GlobeNewsWire

embecta to Report Fiscal First Quarter 2024 Financial Results

PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to ...

4 months ago - GlobeNewsWire

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that it has sub...

4 months ago - GlobeNewsWire

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wed...

5 months ago - GlobeNewsWire

No embecta-made syringes impacted by FDA safety communication

PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug Admi...

6 months ago - GlobeNewsWire

embecta to Participate in Investor Conferences

PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following investor...

6 months ago - GlobeNewsWire

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

PARSIPPANY, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelv...

6 months ago - GlobeNewsWire

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

embecta (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq opening bell in recognition of National Diabetes Awareness Month.

7 months ago - GlobeNewsWire

embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results

PARSIPPANY, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal fourth quarter and full ...

7 months ago - GlobeNewsWire

embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference

PARSIPPANY, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in a fireside chat at the Morgan Stanley 21st Annual Health...

9 months ago - GlobeNewsWire

Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and nine-...

10 months ago - GlobeNewsWire

embecta to Report Fiscal Third Quarter 2023 Financial Results

PARSIPPANY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal third quarter 2023 finan...

11 months ago - GlobeNewsWire

UPDATE -- embecta to Participate in Investor Conferences

PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will par...

1 year ago - GlobeNewsWire

Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financia...

1 year ago - GlobeNewsWire

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes

PARSIPPANY, N.J. and PALO ALTO, Calif., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, and Tidepool, a 50...

1 year ago - GlobeNewsWire

embecta to Report Fiscal Second Quarter 2023 Financial Results

PARSIPPANY, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss...

1 year ago - GlobeNewsWire

embecta sponsors educational symposium at ATTD 2023

Highlights the critical role people with diabetes play in their own care and treatment Highlights the critical role people with diabetes play in their own care and treatment

1 year ago - GlobeNewsWire

Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financi...

1 year ago - GlobeNewsWire